Soft-tissue management: A key factor in contemporary implantology

Dr Khoury, what are the primary goals of soft-tissue management today, and how does it influence clinical outcomes in relation to peri-implant health, aesthetics, patient comfort and long-term stability?
Implant dentistry has reached a high level of technical maturity in recent years. However, long-term success is strongly influenced by the quality and quantity of the peri-implant soft tissue. Beyond purely functional considerations, stability, cleansability and aesthetics have become key priorities. Therefore, soft-tissue management is not an optional add-on; it is an integral component of treatment planning before, during and after augmentation and implant placement.

In the pre-augmentation planning phase, how does your evaluation of the soft tissue influence the overall treatment plan and timing, and which soft-tissue augmentation procedures do you consider standard at this stage?
Within a pre-augmentation treatment concept, the primary focus is initially on rebuilding hard-tissue structures. However, establishing stable, well-vascularised soft-tissue conditions is a decisive prerequisite for successful bone augmentation. Free connective tissue grafts are a commonly used form of soft-tissue augmentation in this context, as they can be used in both the maxilla and mandible and provide reliable increases in peri-implant soft-tissue volume.

Which methods are suitable for soft-tissue management after implant placement?
After implant placement, the focus shifts to long-term stabilisation of the peri-implant tissues. Free mucosal grafts remain an established option for increasing the width of keratinised and attached mucosa. As an adjunct, apically positioned flaps—either alone or combined with connective tissue grafts—can be used to transpose keratinised mucosa vestibularly. Roll-flap techniques are particularly useful in the maxilla for horizontal soft-tissue volume gain and optimisation of the emergence profile. In the aesthetic zone, papilla reconstruction may be required; these measures are planned on an individual basis depending on defect morphology and the available soft-tissue volume.

Looking ahead, what developments do you expect to most influence implant dentistry, and what evidence or clinical needs are driving that change?
Modern implant dentistry is moving towards a biologically driven, comprehensive treatment concept. The clinical need is clear: long-term therapeutic success depends to a large extent on healthy, stable and cleansable peri-implant soft tissue. Therefore, proactive soft-tissue management will therefore become an increasingly important hallmark of high-quality implant care.